| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LianBio | Chief Financial Officer | Ordinary Shares | 325,901 | $538,780 | $1.65 | 29 Mar 2023 | Direct |
| Olema Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 24,150 | 11 Jun 2025 | Direct | ||
| RayzeBio, Inc. | Director | Employee Stock Option (right to buy) | 0 | 26 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 17:00 |
| OLMA | Olema Pharmaceuticals, Inc. | 14 Jun 2024 | 1 | $0 | 4 | Director | 18 Jun 2024, 17:00 |
| /report/000141588924005516-larson-yi-2024-02-26 | RayzeBio, Inc. | 26 Feb 2024 | 3 | $0 | 4 | Director | 27 Feb 2024, 16:51 |
| /report/000120919123049505-larson-yi-2023-09-14 | RayzeBio, Inc. | 14 Sep 2023 | 0 | $0 | 3 | Director | 14 Sep 2023, 19:27 |
| OLMA | Olema Pharmaceuticals, Inc. | 16 Jun 2023 | 1 | $0 | 4 | Director | 21 Jun 2023, 17:00 |
| LIANY | LianBio | 29 Mar 2023 | 1 | $0 | 4 | Chief Financial Officer | 31 Mar 2023, 16:17 |
| LIANY | LianBio | 20 Jan 2023 | 1 | $0 | 4 | Chief Financial Officer | 24 Jan 2023, 15:12 |
| OLMA | Olema Pharmaceuticals, Inc. | 17 Jun 2022 | 1 | $0 | 4/A | Director | 27 Jun 2022, 17:16 |
| OLMA | Olema Pharmaceuticals, Inc. | 16 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 19:32 |
| LIANY | LianBio | 01 Dec 2021 | 1 | $0 | 4 | Chief Financial Officer | 03 Dec 2021, 15:05 |
| LIANY | LianBio | 31 Oct 2021 | 1 | $0 | 4 | Chief Financial Officer | 01 Nov 2021, 19:20 |
| LIANY | LianBio | 29 Oct 2021 | 0 | $0 | 3 | Chief Financial Officer | 29 Oct 2021, 18:16 |
| OLMA | Olema Pharmaceuticals, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 18:36 |